Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 10/20 | 0.50 |
| ▸ | LPL | P06858 | 9/20 | 0.50 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.31 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.31 |
| ▸ | P4HB | P07237 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31386271 | 0.95 | LIPG (0.56) | LIPGLPLPDK2DGAT1PDGFRB | |
| SCHEMBL17986634 | 0.95 | LIPG (0.56) | LIPGLPLPDK2DGAT1PDGFRB | |
| SCHEMBL18458011 | 0.92 | LIPG (0.46) | LIPGLPLPDK2P4HB | |
| SCHEMBL15845388 | 0.90 | LIPG (0.52) | LIPGLPLPDK2DGAT1PDGFRB | |
| SCHEMBL15906974 | 0.90 | LIPG (0.51) | LIPGLPLPDK2DGAT1PDGFRB | |
| SCHEMBL24531298 | 0.90 | LIPG (0.54) | LIPGLPLPDK2DGAT1PDGFRB | |
| SCHEMBL15906991 | 0.90 | LIPG (0.54) | LIPGLPLPDK2DGAT1PDGFRB | |
| SCHEMBL15907004 | 0.89 | LIPG (0.55) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL16383541 | 0.88 | LIPG (0.50) | LIPGLPLPDK2DGAT1PDGFRB | |
| SCHEMBL30951702 | 0.87 | LIPG (0.59) | LIPGLPLPDK2DGAT1PDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10510960-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2019-12-17 | — | — | US | disclosed |
| US-20170338414-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-11-23 | — | — | US | disclosed |
| US-20170338414-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-11-23 | — | — | US | disclosed |
| WO-2016078738-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2016-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170338414-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | L1CAM, EFNA1, EPCAM | LIPG 2479/4885LPL 4031/4885PDK2 1024/4885 |
| US-10510960-B2 | Materials for organic electroluminescent devices | L1CAM, EFNA1, EPCAM | LIPG 2479/4885LPL 4031/4885PDK2 1024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.